HomePVCT • OTCMKTS
add
Provectus Biopharmaceuticals Inc
Previous close
$0.048
Day range
$0.048 - $0.053
Year range
$0.038 - $0.11
Market cap
19.39M USD
Avg Volume
365.36K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 774.88K | -55.39% |
Net income | -1.17M | 50.79% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.02M | 54.93% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 251.29K | -18.26% |
Total assets | 697.50K | -30.68% |
Total liabilities | 7.00M | 0.35% |
Total equity | -6.30M | — |
Shares outstanding | 420.28M | — |
Price to book | -2.41 | — |
Return on assets | -458.12% | — |
Return on capital | 72.63% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.17M | 50.79% |
Cash from operations | -869.55K | 4.66% |
Cash from investing | — | — |
Cash from financing | 1.05M | 32.95% |
Net change in cash | 178.81K | 243.67% |
Free cash flow | -617.09K | -760.71% |
About
Founded
2002
Headquarters
Website
Employees
6
